Piraye Yurttas Beim, PhD

@DDNewsOnline's @NatOrtolano interviews our CEO Dr. @pirayebeim in headlining article "Is Anti-Müllerian Hormone the New Estrogen?" bit.ly/34jKs5z #WomensHealth #biotech

“AMH and its receptor are really the missing hormonal pathway in the pantheon of key reproductive pathways regulating the ovaries. We are seeing it emerge as a very exciting therapeutic target,” @pirayebeim from @celmatix told me in my latest story. drugdiscoverynews.com/anti-mllerian-…

@Forbes' @MarijaButkovic interviews our CEO Dr. @pirayebeim on why we coined #ovarianhealth, and our AMH drug program and it's potential in #menopause bit.ly/3CNpuJ2 #WomensHealth #Biotechnology

@wah__yan Thank you! The admiration is mutual!

Validation of our 1st #pcos #drugdiscovery program by our partners at @Evotec and @Bayer #womenshealth bwnews.pr/3fBozAE

"We are confident that the proprietary data in our in-silico discovery platform, paired with our deep expertise in female biology, will unlock novel biological insights & drive innovation in #womenshealth therapeutic development." @pirayebeim @celmatix femtechinsider.com/celmatix-evote…

Such a fun time reliving the early days of @celmatix with David’s class today. @dbsable

Weaving together the demands of advanced clinical trials with expanding options for business development, the importance of “tough but fair.” Plus a great guest speaker— @pirayebeim, CEO of @celmatix. Tomorrow in #Entrepreneurship in #Biotechnology @Columbia

Today, FDA approved the first COVID-19 vaccine for the prevention of #COVID19 disease in individuals 16 years of age and older. fda.gov/news-events/pr…

Huge congratulations to a team that always takes the hard road rather than the “wellness” road. Another great FDA milestone for @NaturalCycles .

Dr. Roberta Brinton (@RobbieBrain), Director of @UAZCIBS, is a champion for women-focused #Alzheimers research. We need to increase funding for #SABV research, so she and other researchers can advance their groundbreaking work. #AlzheimersAwarenessMonth sciencetimes.com/articles/31136…

"As someone who has been innovating in women’s health for over 20 years, I can tell you that there has been a sea change over the last 18 months in the attitude and desire to fund women’s health."@pirayebeim CEO and Founder of @celmatix bit.ly/3vJ7evV

@StephanieKuku @PeterDiamandis @jenngarrison @BuckInstitute @chrissyfarr Exciting to see more attention on reproductive longevity!

.⁦@PeterDiamandis⁩ speaking to ⁦@jenngarrison⁩ of ⁦@BuckInstitute⁩ on Reproductive Longevity. Looking forward to this ⁦@chrissyfarr⁩ ⁦@pirayebeim⁩ diamandis.com/reproductive-l…

"Women’s health is so much bigger than periods and pregnancy" - @chrissyfarr @pirayebeim @deenashakir and @lilymshaw weigh in on the opportunity in women's health.

"As a 30 year veteran of therapeutic discovery and development in women’s health, I know there are less-than-ideal solutions to treat conditions that affect women." @celmatix #biotech #womenshealth femtechinsider.com/stephen-palmer…

#PCOS is often dismissed as a #womenshealth issue, meaning that "Over the past year, we've learned about numerous preexisting health conditions that put a person at higher risk for severe Covid-19 illness, but PCOS isn't one of them." - cnn.com/2021/05/23/hea…

@kwameulmer @chrissyfarr @TracyMacNeal Thank goodness for amazing leaders like her taking on these important challenges!

@kwameulmer @chrissyfarr @TracyMacNeal I learned from @TracyMacNeal that the leading reason that women end up in nursing homes is urinary incontinence. I received exactly zero minutes of counseling about this before or after my three labor/deliveries even though I had wonderful OBGYNs.

Reading some responses to interview q's from @pirayebeim for my newsletter and I'm digging her suggestion of a Softbank Vision Fund dedicated to women's health. As she puts it: "It’s going to take investors with deep conviction and deep pockets to really transform this field."

@susan_bewley @pash22 @celmatix @bethkowitt There is also a strong case for a broader population of women being able to optimize and extend their ovarian function as well but not sure twitter is the best venue for discussing. :)

@susan_bewley @pash22 @celmatix @bethkowitt We are focused initially on women who go into early menopause because of chemotherapy exposure. Those women are at a significantly increased risk for multiple chronic conditions including heart disease by the age of 70 due to their ovarian failure.

This US biotech startup thinks it can delay menopause by 15 years. That would transform women’s lives: @celmatix 's founder @pirayebeim wants to redefine ovarian health to delay the health issues associated with menopause. fortune.com/2021/04/19/cel… via @bethkowitt @susan_bewley